[ET Net News Agency, 1 February 2024] MEDBOT-B (02252) fell 2.3% to HK$11.14.
It hits an intra-day low of HK$11.1, hitting a historical low, and an intra-day high of
HK$11.76. The total shares traded was 583,600, with a value of HK$6.7m. The active
buy/sell ratio is 47:53, with net selling turnover of HK$341,660. GOLDMAN SACHS (ASIA) SEC
accounts for greatest net responsive buying turnover of HK$451,149, with volume weighted
average price of HK$11.443. SHENWAN HONGYUAN SEC accounts for greatest net responsive
selling turnover of HK$524,970, with volume weighted average price of HK$11.475. The stock
has fallen a combined 19.3% over the past 3 consecutive trading days.
Basic Information
=================
----------------------------------
Nominal 11.140 % Chg -2.28%
High 11.760 Low 11.100
Shares Tr 583,600 Turnover 6.7m
10-D SMA 13.228 %H.V 87.197
20-D SMA 14.708 VWAP 11.481
50-D SMA 17.611 RSI14 25.504
----------------------------------
Status: Hitting a historical low, active buy/sell ratio is 47:53, with net selling
turnover of HK$341,660, falling a combined 19.3% over the past 3 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
--------------------------------------------
MEDBOT-B (02252) 11.14 -2.28
MICROPORT (00853) 5.86 +1.56
WEIGAO GROUP (01066) 5.27 +5.19
LIFETECH SCI (01302) 1.75 +2.34
AK MEDICAL (01789) 4.59 +0.22
CARDIOFLOW-B (02160) 1.40 -9.68
UNI MEDICAL (02666) 4.09 +2.25
NH HEALTH (06606) 17.26 +1.77
ANGELALIGN (06699) 55.15 +3.67
JENSCARE-B (09877) 13.92 +0.29
--------------------------------------------
(ed)